Avelumab and Radiation in Muscle-Invasive Bladder Cancer

NCT03747419 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
14
Enrollment
OTHER
Sponsor class

Stopped In agreement with the drug sponsor and the institution, the trial has been terminated due to slow accrual.

Conditions

Interventions

Sponsor

Dana-Farber Cancer Institute

Collaborators